Transplantation with a past positive crossmatch and cyclosporine immunosuppression: A 5‐year experience
- 1 December 1988
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 2 (6) , 336-340
- https://doi.org/10.1111/j.1399-0012.1988.tb00521.x
Abstract
Transplantation of the highly sensitized patient continues to be a major problem. Since 1981, patients with a positive crossmatch using historical sera, but negative using current sera, have been accepted for transplantation. Initially, serum samples were required to be negative for 18 months preceding transplantation; this period has been reduced to 6 months. All patients received pretransplant transfusions; kidneys were transplanted to the ABO‐compatible recipient who was longest on the waiting list. Between January 1983 and January 1988, 230 adult recipients underwent cadaver transplantation and were immunosuppressed with prednisone and cyclosporine. Outcome was compared between those with (n = 64) and those without (n = 166) past positive crossmatches. There was no difference in HLA or DR matching. Patients with past positive crossmatches had significantly higher (p < .05) peak and current PRA. There was no difference in actuarial patient or graft survival for those with and without past positive crossmatches for both first transplants (past pos n = 47; all neg n = 149) and retransplants (past pos n = 17; all neg n = 17). Similarly, there was no difference in need for dialysis in the 1st week, graft loss in the 1st month, or mean current creatinine level. Interestingly, first transplant recipients without past positives had a higher incidence of rejection in the first 2 wk (p < .05). We conclude that renal transplantation with a past positive but current negative crossmatch is compatible with good patient and graft survival.This publication has 14 references indexed in Scilit:
- Outcome of renal transplantation following a positive cross-match with historical sera: The ASHI surveyHuman Immunology, 1985
- SUCCESSFUL CADAVER KIDNEY TRANSPLANTATION IN PATIENTS HIGHLY SENSITIZED BY BLOOD TRANSFUSIONSTransplantation, 1985
- CADAVER RENAL TRANSPLANTATION IGNORING PEAKREACTIVE SERA IN PATIENTS WITH MARKEDLY DECREASING PRETRANSPLANT SENSITIZATIONTransplantation, 1984
- SUCCESSFUL KIDNEY TRANSPLANTATION WITH CURRENT-SERA-NEGATIVE/HISTORICAL-SERA-POSTIVE T CELL CROSSMATCHTransplantation, 1984
- SUCCESSFUL RENAL TRANSPLANTATION IN PATIENTS WITH T-CELL REACTIVITY TO DONORThe Lancet, 1982
- Current Results and Expectations of Renal TransplantationJAMA, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- SUCCESSFUL KIDNEY TRANSPLANT IN PATIENT WITH POSITIVE CROSSMATCH DUE TO AUTOANTIBODIESTransplantation, 1976
- IMPORTANCE OF THE AUTOCONTROL CROSSMATCH IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1976
- Prolonged Survival of Human-Kidney Homografts by Immunosuppressive Drug TherapyNew England Journal of Medicine, 1963